Diagnosis and management of hereditary angioedema: an American approach

被引：33

作者：

Zuraw, BL ^{[1
]}

机构：

[1] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA

来源：

TRANSFUSION AND APHERESIS SCIENCE | 2003年 / 29卷 / 03期

关键词：

HAE; C1; inhibitor; anabolic androgens; epsilon aminocaproic acid;

D O I：

10.1016/j.transci.2003.08.008

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Hereditary angioedema (HAE) is an autosomal dominant disease characterized by recurrent episodes of angioedema. and caused by a deficiency of the plasma protein Cl inhibitor. HAE attacks carry a substantial risk of morbidity or even mortality, making it imperative that the correct diagnosis be established and an appropriate management plan be in place. This report reviews the current diagnostic and therapeutic approaches available in the United States. Areas in which the diagnostic or therapeutic tools are deficient are discussed, and the prospects for improved therapeutic modalities highlighted. (C) 2003 Elsevier Ltd. All rights reserved.

引用

页码：239 / 245

页数：7

共 50 条

[41] Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group
Cicardi, M.
Aberer, W.
Banerji, A.
Bas, M.
Bernstein, J. A.
Bork, K.
Caballero, T.
Farkas, H.
Grumach, A.
Kaplan, A. P.
Riedl, M. A.
Triggiani, M.
Zanichelli, A.
Zuraw, B.
ALLERGY, 2014, 69 (05) : 602 - 616
[42] Review of consensus approaches to the diagnosis, therapy, and management of hereditary angioedema, circa 2009
Bowen, Tom
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2010, 30 : 9 - 19
[43] Canadian 2003 international consensus algorithm for the diagnosis, therapy, and management of hereditary angioedema
Bowen, T
Cicardi, M
Farkas, H
Bork, K
Kreuz, W
Zingale, L
Varga, L
Martinez-Saguer, I
Aygören-Pürsün, E
Binkley, K
Zuraw, B
Davis, A
Hebert, J
Ritchie, B
Burnham, J
Castaldo, A
Menendez, A
Nagy, I
Harmat, G
Bucher, C
Lacuesta, G
Issekutz, A
Warrington, R
Yang, W
Dean, J
Kanani, A
Stark, D
McCusker, C
Wagner, E
Rivard, GE
Leith, E
Tsai, E
MacSween, M
Lyanga, J
Serushago, B
Leznoff, A
Waserman, S
de Serres, J
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2004, 114 (03) : 629 - 637
[44] An Update on the Diagnosis and Management of Hereditary Angioedema With Abnormal C1 Inhibitor
Davis-Lorton, Mark
JOURNAL OF DRUGS IN DERMATOLOGY, 2015, 14 (02) : 151 - 157
[45] Current Management Options for Hereditary Angioedema
Bork, Konrad
CURRENT ALLERGY AND ASTHMA REPORTS, 2012, 12 (04) : 273 - 280
[46] Hereditary angioedema: Management of laryngeal attacks
Christiansen, Sandra C.
Zuraw, Bruce L.
AMERICAN JOURNAL OF RHINOLOGY & ALLERGY, 2011, 25 (06) : 379 - 382
[47] WAO Guideline for the Management of Hereditary Angioedema
Craig, Timothy
Pueruesn, Emel Aygoeren
Bork, Konrad
Bowen, Tom
Boysen, Henrik
Farkas, Henriette
Grumach, Anete
Katelaris, Constance H.
Lockey, Richard
Longhurst, Hilary
Lumry, William
Magerl, Markus
Martinez-Saguer, Immaculada
Ritchie, Bruce
Nast, Alexander
Pawankar, Ruby
Zuraw, Bruce
Maurer, Marcus
WORLD ALLERGY ORGANIZATION JOURNAL, 2012, 5 : 182 - 199
[48] Anaesthetic Management of a Patient with Hereditary Angioedema
Turktan, Mediha
Gulec, Ersel
Hatipoglu, Zehra
Kucubingoz, Cgatay
Yilmaz, Mustafa
Gunes, Yasemin
TURKISH JOURNAL OF ANAESTHESIOLOGY AND REANIMATION, 2014, 42 (04) : 217 - 219
[49] Management of cholelithiasis in patients with hereditary angioedema
Cockbain, A. J.
Dave, R.
Gooi, H. C.
Toogood, G. J.
BRITISH JOURNAL OF SURGERY, 2011, 98 : 71 - 72
[50] Management of hereditary angioedema in pediatric patients
Farkas, Henriette
Varga, Lilian
Szeplaki, Gabor
Visy, Beata
Harmat, George
Bowen, Tom
PEDIATRICS, 2007, 120 (03) : E713 - E722

← 1 2 3 4 5 →